Colchicine as a potent anti-inflammatory treatment in COVID-19: Can we teach an old dog new tricks?

European Heart Journal - Cardiovascular Pharmacotherapy

Volumn 6, Issue 4, 2020, Pages 255-

  Deftereos, Spyridon ^a   Giannopoulos, George ^b   Vrachatis, Dimitrios A ^a,c   Siasos, Gerasimos ^a   Giotaki, Sotiria G ^a   Cleman, Michael ^d   Dangas, George ^e   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b KAT HOSPITAL   (Greece)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COLCHICINE; LOPINAVIR PLUS RITONAVIR; TROPONIN; INFLAMMASOME; ION CHANNEL; TUBULIN MODULATOR; VIRAL PROTEIN; VIROPORINS;

CLINICAL EVALUATION; CORONAVIRUS DISEASE 2019; DRUG EFFICACY; HIGH RISK PATIENT; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LETTER; MORTALITY; OUTPATIENT; TREATMENT DURATION; BETACORONAVIRUS; CORONAVIRUS INFECTION; IMMUNOLOGY; PANDEMIC; VIRUS PNEUMONIA;

BETACORONAVIRUS; COLCHICINE; CORONAVIRUS INFECTIONS; HUMANS; INFLAMMASOMES; ION CHANNELS; PANDEMICS; PNEUMONIA, VIRAL; TUBULIN MODULATORS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 85084616520     PISSN: 20556837     EISSN: 20556845     Source Type: Journal    
DOI: 10.1093/EHJCVP/PVAA033     Document Type: Letter

References (9)

1. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;doi: 10.1001/jamacardio.2020.1017.
2. Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, Sepe PA, Resasco T, Camporotondo R, Bruno R, Baldanti F, Paolucci S, Pelenghi S, Iotti GA, Mojoli F, Arbustini E. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail 2020;doi: 10.1002/ejhf.1828.
3. Castaño-Rodriguez C, Honrubia JM, Gutiérrez-Álvarez J, DeDiego ML, Nieto-Torres JL, Jimenez-Guardeño JM, Regla-Nava JA, Fernandez-Delgado R, Verdia-Báguena C, Queralt-Martín M, Kochan G, Perlman S, Aguilella VM, Sola I, Enjuanes L. Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in replication and pathogenesis. MBio 2018;9:e02325-17.
4. Misawa T, Takahama M, Kozaki T, Lee H, Zou J, Saitoh T, Akira S. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol 2013;14:454-460.
5. Vrachatis DA, Giannopoulos G, Deftereos SG. Colchicine: conventional and contemporary indications. Curr Pharm Des 2018;24:647-647.
6. Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, Berry C, López-Sendón J, Ostadal P, Koenig W, Angoulvant D, Grégoire JC, Lavoie MA, Dubé MP, Rhainds D, Provencher M, Blondeau L, Orfanos A, L'Allier PL, Guertin MC, Roubille F. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 2019;381:2497-2505.
7. Deftereos S, Giannopoulos G, Angelidis C, Alexopoulos N, Filippatos G, Papoutsidakis N, Sianos G, Goudevenos J, Alexopoulos D, Pyrgakis V, Cleman MW, Manolis AS, Tousoulis D, Lekakis J. Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study. Circulation 2015;132:1395-1403.
8. Deftereos S, Giannopoulos G, Papoutsidakis N, Panagopoulou V, Kossyvakis C, Raisakis K, Cleman MW, Stefanadis C. Colchicine and the heart: pushing the envelope. J Am Coll Cardiol 2013;62:1817-1825.
9. Deftereos SG, Siasos G, Giannopoulos G, Vrachatis DA, Angelidis C, Giotaki SG, Gargalianos P, Giamarellou H, Gogos C, Daikos G, Lazanas M, Lagiou P, Saroglou G, Sipsas N, Tsiodras S, Chatzigeorgiou D, Moussas N, Kotanidou A, Koulouris N, Oikonomou E, Kaoukis A, Kossyvakis C, Raisakis K, Fountoulaki K, Comis M, Tsiachris D, Sarri E, Theodorakis A, Martinez-Dolz L, Jorge S-S, Reimers B, Stefanini GG, Cleman M, Filippou D, Olympios CD, Pyrgakis VN, Goudevenos J, Hahalis G, Kolettis TM, Iliodromitis E, Tousoulis D, Stefanadis C. The GReek study in the Effects of Colchicine in COvid-19 complications prevention (GRECCO-19 study): rationale and study design. Hellenic J Cardiol 2020;doi: 10.1016/j.hjc.2020.03.002.